Last reviewed · How we verify

miconazole 2% oil

Hill Dermaceuticals, Inc. · Phase 2 active Small molecule

miconazole 2% oil is a Small molecule drug developed by Hill Dermaceuticals, Inc.. It is currently in Phase 2 development. Also known as: active treatment.

At a glance

Generic namemiconazole 2% oil
Also known asactive treatment
SponsorHill Dermaceuticals, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about miconazole 2% oil

What is miconazole 2% oil?

miconazole 2% oil is a Small molecule drug developed by Hill Dermaceuticals, Inc..

Who makes miconazole 2% oil?

miconazole 2% oil is developed by Hill Dermaceuticals, Inc. (see full Hill Dermaceuticals, Inc. pipeline at /company/hill-dermaceuticals-inc).

Is miconazole 2% oil also known as anything else?

miconazole 2% oil is also known as active treatment.

What development phase is miconazole 2% oil in?

miconazole 2% oil is in Phase 2.

Related